Adaptive Biotechnologies reported a gross margin of 71.82% and a net margin of -22.65% for the quarter ended Jun 2026. These financial ratios cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||
| Gross Margin | 64.05% | 62.15% | 65.84% | 69.72% | 68.83% | 69.95% | 50.38% | 63.39% | 48.98% | 57.16% | 56.89% | 55.27% | 64.11% | 61.98% | 67.62% | 69.43% | 80.68% | 74.58% | 73.60% | 71.82% | |||||||||||||
| EBT Margin | -141.89% | -161.76% | -162.60% | -119.29% | -94.75% | -72.77% | -153.27% | -97.72% | -132.72% | -151.73% | -113.52% | -107.08% | -69.12% | -71.04% | -56.88% | -43.47% | 10.16% | -18.94% | -28.24% | -22.65% | |||||||||||||
| EBIT Margin | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -151.92% | -97.74% | -134.38% | -155.22% | -116.45% | -109.56% | -70.27% | -71.30% | -56.45% | -42.52% | 10.95% | -17.82% | -27.10% | -22.04% | |||||||||||||
| EBITDA Margin | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -98.54% | -50.73% | -78.67% | -21.75% | -67.30% | -49.66% | -30.80% | -3.61% | -17.58% | -10.31% | 32.64% | 11.84% | 17.13% | -22.04% | |||||||||||||
| Operating Margin | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -151.92% | -97.74% | -134.38% | -155.22% | -116.45% | -109.56% | -70.27% | -71.30% | -56.45% | -42.52% | 10.95% | -17.82% | -27.10% | -22.04% | |||||||||||||
| Net Margin | -141.89% | -161.76% | -162.60% | -119.29% | -94.75% | -72.77% | -153.27% | -97.72% | -132.72% | -151.73% | -113.52% | -107.08% | -69.12% | -71.04% | -56.88% | -43.47% | 10.16% | -18.94% | -28.24% | -22.65% | |||||||||||||
| FCF Margin | -147.12% | -166.28% | -174.86% | -119.93% | -100.02% | -58.99% | -164.89% | -55.70% | -130.44% | -61.66% | -95.20% | -44.07% | -59.03% | -26.49% | -56.71% | -22.22% | -8.02% | 1.98% | -14.58% | -10.60% | |||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 18.42M | 18.75M | 20.13M | 19.89M | 18.06M | 15.90M | 17.16M | 19.42M | 19.23M | 16.97M | 13.87M | 13.25M | 12.58M | 10.20M | 8.56M | 8.54M | 9.17M | 9.88M | 10.51M | 10.85M | |||||||||||||
| Assets AverageAssets Avg. | 1,012.99M | 957.98M | 890.77M | 832.41M | 845.42M | 870.41M | 824.04M | 778.00M | 741.11M | 689.41M | 640.73M | 602.60M | 571.69M | 548.94M | 525.11M | 503.74M | 493.62M | 501.67M | 509.34M | 573.31M | |||||||||||||
| Invested CapitalInvested Cap. | 589.46M | 491.56M | 438.94M | 406.31M | 373.51M | 356.27M | 335.76M | 323.78M | 313.10M | 336.27M | 356.21M | 354.79M | 150.66M | ||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.14 | 0.16 | 0.17 | 0.19 | 0.20 | 0.21 | 0.22 | 0.24 | 0.24 | 0.25 | 0.27 | 0.28 | 0.31 | 0.33 | 0.36 | 0.41 | 0.51 | 0.55 | 0.58 | 0.54 | |||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -69.57 | -10.93 | -16.20 | -13.26 | -13.95 | -23.59 | -16.29 | -17.55 | -11.10 | -11.46 | -10.19 | -8.49 | 3.46 | -4.32 | -6.65 | -5.85 | |||||||||||||||||
| Debt Ratio | 0.15 | 0.18 | 0.20 | 0.21 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.27 | 0.26 | 0.26 | |||||||||||||||||||||
| Times Interest Earned | -69.57 | -10.93 | -16.20 | -13.26 | -13.95 | -23.59 | -16.29 | -17.55 | -11.10 | -11.46 | -10.19 | -8.49 | 3.46 | -4.32 | -6.65 | -5.85 | |||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -85.60 | -64.66 | -31.43 | -22.18 | -22.46 | -27.22 | -22.08 | -20.30 | -15.68 | -10.23 | -9.95 | -11.54 | -23.54 | -26.25 | -37.84 | -69.30 | 239.14 | -183.91 | -110.75 | -210.50 | |||||||||||||
| Price to SalesP/S | 121.46 | 104.60 | 51.10 | 26.46 | 21.29 | 19.81 | 33.84 | 19.84 | 20.81 | 15.53 | 11.30 | 12.36 | 16.27 | 18.65 | 21.52 | 30.12 | 24.29 | 34.84 | 31.28 | 47.68 | |||||||||||||
| Price to BookP/B | 7.36 | 6.57 | 3.57 | 2.23 | 2.09 | 2.36 | 3.01 | 2.45 | 2.18 | 2.31 | 1.72 | 2.21 | 3.38 | 4.37 | 5.93 | 9.88 | 11.17 | 11.10 | 9.88 | 22.65 | |||||||||||||
| Enterprise Value | 4,378.52M | 3,614.56M | 1,609.99M | 771.40M | 509.96M | 595.06M | 833.23M | 553.27M | 417.78M | 364.38M | 164.03M | 241.76M | 511.99M | 662.65M | 935.12M | 1,575.48M | 2,069.66M | 2,276.61M | 2,006.16M | 3,075.32M | |||||||||||||
| EV to EBIT | -77.74 | -58.68 | -25.53 | -14.69 | -11.23 | -15.19 | -14.57 | -11.57 | -8.20 | -5.13 | -3.36 | -5.11 | -15.69 | -19.58 | -31.59 | -62.93 | 201.13 | -178.24 | -104.46 | -195.01 | |||||||||||||
| EV to EBITDA | -77.74 | -58.68 | -25.53 | -14.69 | -11.23 | -15.19 | -22.46 | -22.29 | -14.01 | -36.60 | -5.82 | -11.27 | -35.80 | -387.29 | -101.46 | -259.59 | 67.48 | 268.34 | 165.28 | -195.01 | |||||||||||||
| Market Capitalization | 4,793.52M | 3,967.51M | 1,973.50M | 1,155.13M | 1,018.07M | 1,093.32M | 1,273.99M | 970.57M | 789.01M | 710.90M | 473.05M | 533.81M | 755.52M | 885.16M | 1,128.74M | 1,773.54M | 2,282.61M | 2,497.38M | 2,216.60M | 3,411.83M | |||||||||||||
| Price to FCFP/FCF | -82.56 | -62.91 | -29.22 | -22.06 | -21.28 | -33.58 | -20.52 | -35.61 | -15.95 | -25.18 | -11.87 | -28.05 | -27.56 | -70.41 | -37.95 | -135.54 | -302.89 | 0.00M | -214.52 | -449.87 | |||||||||||||
| EV to FCF | -75.41 | -57.31 | -23.84 | -14.73 | -10.66 | -18.28 | -13.42 | -20.30 | -8.45 | -12.91 | -4.11 | -12.70 | -18.68 | -52.71 | -31.44 | -120.40 | -274.64 | 0.00M | -194.15 | -405.50 | |||||||||||||
| EV to CFO | -100.79 | -67.15 | -24.98 | -16.39 | -12.03 | -19.82 | -14.09 | -23.49 | -8.95 | -13.53 | -4.28 | -13.97 | -18.92 | -53.05 | -32.83 | -126.75 | -290.40 | 0.00M | -210.36 | -480.52 | |||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -151.92% | -97.74% | -134.38% | -155.22% | -116.45% | -109.56% | -70.27% | -71.30% | -56.45% | -42.52% | 10.95% | -17.82% | -27.10% | -22.04% | |||||||||||||
| Return on Capital Employed [ROCE]ROCE | -21.51% | -24.75% | -29.75% | -32.39% | -30.02% | -26.32% | -26.48% | -27.78% | -30.12% | -37.75% | -39.19% | -42.39% | -41.27% | -36.05% | -32.79% | -29.42% | -19.06% | -13.87% | -11.06% | -7.71% | |||||||||||||
| Return on Assets [ROA]ROA | -18.70% | -21.64% | -25.76% | -27.90% | -26.21% | -23.02% | -23.70% | -24.55% | -26.45% | -32.68% | -33.58% | -35.44% | -34.17% | -29.07% | -27.02% | -24.07% | -16.12% | -11.85% | -9.75% | -7.02% |